A Transgenic Model of Visceral Obesity and the Metabolic Syndrome
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
The adverse metabolic consequences of obesity are best predicted by the quantity of visceral fat. Excess glucocorticoids produce visceral obesity and diabetes, but circulating glucocorticoid levels are normal in typical obesity. Glucocorticoids can be produced locally from inactive 11-keto forms through the enzyme 11β hydroxysteroid dehydrogenase type 1 (11β HSD-1). We created transgenic mice overexpressing 11β HSD-1 selectively in adipose tissue to an extent similar to that found in adipose tissue from obese humans. These mice had increased adipose levels of corticosterone and developed visceral obesity that was exaggerated by a high-fat diet. The mice also exhibited pronounced insulin-resistant diabetes, hyperlipidemia, and, surprisingly, hyperphagia despite hyperleptinemia. Increased adipocyte 11β HSD-1 activity may be a common molecular etiology for visceral obesity and the metabolic syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“other health outcomes associated with better quality of life improved, including sleep apnoea136 and mobility137.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [137]
Citations
Cites
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,237
Role of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117
Self-citationSubcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Ahima, R. S., & Flier, J. S. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.413 · Cited by 1,428
Self-citationThe Degree of Masculine Differentiation of Obesities
VAGUE, J. (1956) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/4.1.20 · Cited by 1,410
Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver
Abel, E. D., Peroni, O., Kim, J. K., Kim, Y.-B., Boss, O., Hadro, E., Minnemann, T., Shulman, G. I., & Kahn, B. B. (2001) · Nature · doi:10.1038/35055575 · Cited by 1,253
Frühbeck, G., Gómez-Ambrosi, J., Muruzábal, F. J., & Burrell, M. A. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.6.e827 · Cited by 974
Research works printed but not linked: 5
- 10.1210/jcem.86.3.7453 · doi:10.1210/jcem.86.3.7453 · Paper page
- 10.1101/gad.7.7b.1318 · doi:10.1101/gad.7.7b.1318 · Paper page
- Supplementary data are available on Science Online at www.sciencemag.org/cgi/content/full/294/5549/2166/DC1.
- Strack A. M., Bradbury M. J., Dallman M. F., Am. J. Physiol. 268, R183 (1995).
- 10.1210/jcem.83.5.4951 · doi:10.1210/jcem.83.5.4951 · Paper page
Cited by
Items 301–400 of 1,003
Association of Diurnal Patterns in Salivary Cortisol With Type 2 Diabetes in the Whitehall II Study
Hackett, R. A., Steptoe, A., & Kumari, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2459 · Cited by 118
“Research has shown that transgenic mice overexpressing 11 -hydroxysteroid dehydrogenase type 1 (11 -HSD1), the enzyme activating the inactive form of glucocorticoids, have increased adipose levels of corticosterone (28).”
BackgroundCorticosteroid receptors, macrophages and cardiovascular disease
Rickard, A. J., & Young, M. J. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0144 · Cited by 118
Lo, K. A., Labadorf, A., Kennedy, N. J., Han, M. S., Yap, Y. S., Matthews, B., Xin, X., Sun, L., Davis, R. J., Lodish, H. F., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.039 · Cited by 107
“Elevated endogenous glucocorticoid (e.g., the hormone cortisol in humans and corticosterone in rodents) can also lead to visceral obesity andaggravate high-fat, diet-induced insulin resistance (Masuzaki et al., 2001;Wang, 2005).”
Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease
Hadoke, P. W. F., Iqbal, J., & Walker, B. R. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00047.x · Cited by 99
“, 1997; 1999) and over-expression (Masuzaki et al., 2001; 2003; Paterson et al., 2004) of 11-HSD isozymes has been invaluable in this respect.”
BackgroundInfluentialGlucocorticoids as mediators of developmental programming effects
Khulan, B., & Drake, A. J. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.03.007 · Cited by 118
Anagnostis, P. G., Katsiki, N., Adamidou, F., Athyros, V. G., Karagiannis, A. I., Kita, M. D., & Mikhailidis, D. P. (2012) · Metabolism · doi:10.1016/j.metabol.2012.05.002 · Cited by 116
“All these studies [7,21–29,32–34,37–39] suggest that increased 11β-HSD1 mRNA expression and activity are implicated in the pathogenesis of obesity and insulin resistance”
BackgroundInfluentialFujimoto, M., Masuzaki, H., Tanaka, T., Yasue, S., Tomita, T., Okazawa, K., Fujikura, J., Chusho, H., Ebihara, K., Hayashi, T., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.09.027 · Cited by 100
Self-citationA Switch in Hepatic Cortisol Metabolism across the Spectrum of Non Alcoholic Fatty Liver Disease
Ahmed, A., Rabbitt, E., Brady, T., Brown, C., Guest, P., Bujalska, I. J., Doig, C., Newsome, P. N., Hubscher, S., Elias, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029531 · Cited by 115
“Conversely recombinant mice with global deletion of 11b-HSD1 are protected from many of these features including hepatic steatosis [24,25].”
BackgroundAlessi, J., de Oliveira, G. B., Schaan, B. D., & Teló, G. H. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00583-7 · Cited by 115
Moreno‐Navarrete, J. M., & Fernández‐Real, J. M. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0965-6_2 · Cited by 115
Bernal‐Mizrachi, C., Xiaozhong, L., Li, Y., Knutsen, R. H., Howard, M. J., Arends, J. J. A., DeSantis, P., Coleman, T., & Semenkovich, C. F. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2006.12.010 · Cited by 115
“Glucocorticoid excess, whether caused by exogenous administration, endogenous overproduction associated with Cushing’s syndrome, or accelerated conversion of inactive to active glucocorticoids in tissues (Masuzaki et al. 2001;Paterson et al. 2004) alters lipid metabolism and produces insulin resistance.”
BackgroundModulation of glucose metabolism by the renin-angiotensin-aldosterone system
Favre, G. A., Esnault, V. L. M., & Van Obberghen, E. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00391.2014 · Cited by 114
“In addition, Tg mice with overexpression of 11 -HSD1 in WAT have hypertrophic visceral adipocytes; they are insulin resistant and hyperglycemic when submitted to an intraperitoneal glucose load (120).”
BackgroundWhite Adipose Tissue: Getting Nervous
Fliers, E., Kreier, F., Voshol, P. J., Havekes, L. M., Sauerwein, H. P., Kalsbeek, A., Buijs, R. M., & Romijn, J. A. (2003) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2003.01096.x · Cited by 114
Smart, J. L. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25243 · Cited by 99
Hosfield, D. J., Wu, Y., Skene, R. J., Hilgers, M., Jennings, A., Snell, G. P., & Aertgeerts, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411104200 · Cited by 102
Hughes, K. A., Webster, S. P., & Walker, B. R. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.4.481 · Cited by 102
“Drugs (2008) 17(4) 483 have normal serum glucocorticoid levels, as in human obesity [42] .”
Sinclair, A. J., Walker, E. A., Burdon, M. A., van Beek, A. P., Kema, I. P., Hughes, B. A., Murray, P. I., Nightingale, P. G., Stewart, P. M., Rauz, S., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0729 · Cited by 103
“J Clin Endocrinol Metab, December 2010, 95(12):5348–5356 jcem.”
BackgroundInfluentialLivingstone, D. E. W., Barat, P., Di Rollo, E. M., Rees, G. A., Weldin, B. A., Rog-Zielinska, E. A., MacFarlane, D. P., Walker, B. R., & Andrew, R. (2015) · Diabetes · doi:10.2337/db14-0249 · Cited by 100
“This has been elegantly demonstrated by adverse metabolic phenotypes in mice overexpressing the glucocorticoid-regenerating enzyme 11b-hydroxysteroid dehydrogenase type 1 in liver (29) and adipose tissue (30).”
BackgroundSchweizer, R. A. S., Atanasov, A. G., Frey, B. M., & Odermatt, A. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.09.027 · Cited by 112
Stewart, P. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490163 · Cited by 105
“‘Cushing’s disease of the omentum’, mediated via the autocrine expression of 11b-HSD1, may explain the propensity of an individual to develop a central obese phenotype, an hypothesis that is supported through the phenotype of transgenic mice with targeted overexpression of 11b-HSD1 in adipose tissue ( 23 ).”
BackgroundEl-Atat, F. A., Aneja, A., McFarlane, S. I., & Sowers, J. R. (2003) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(03)00070-7 · Cited by 112
Models and mechanisms for hippocampal dysfunction in obesity and diabetes
Stranahan, A. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.045 · Cited by 103
“…example of a transgenic model with increased vWAT is the aP2-11betaHSD1 overexpressing mouse, in which the glucocorticoid-amplifying enzyme 11betahydroxysteroid dehydrogenase 1 (11betaHSD1) is overexpressed under the adipocyte fatty acid binding protein 2 (aP2) promoter (Masuzaki et al., 2001).”
BackgroundInfluentialDetrimental and protective fat: body fat distribution and its relation to metabolic disease
Booth, A., Magnuson, A., & Foster, M. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0009 · Cited by 97
The epidemic of obesity and changes in food intake: the Fluoride Hypothesis
Bray, G. A. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.04.033 · Cited by 111
Cortisol correlates with metabolic disturbances in a population study of type 2 diabetic patients
Oltmanns, K. M., Dodt, B., Schultes, B., Raspe, H. H., Schweiger, U., Born, J., Fehm, H. L., & Peters, A. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02074 · Cited by 99
“Masuzaki et al. ( 15 ) reported that transgenic mice overexpressing 11b-hydroxysteroid dehydrogenase type 1 (11beta-HSD1), the enzyme activating the inactive form of glucocorticoids, show (in combination with several metabolic abnormalities) increased adipose levels of corticosterone although circulating glucocorticoi…”
BackgroundThe Contribution of Visceral Adipose Tissue to Splanchnic Cortisol Production in Healthy Humans
Andrew, R., Westerbacka, J., Wahren, J., Yki-Järvinen, H., & Walker, B. R. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1364 · Cited by 98
“7-fold increase in enzyme activity and a twofold increase in visceral fat mass, which is associated with an 500 nmol/l increase in portal vein corticosterone concentrations (2).”
BackgroundHussain, T., Murtaza, G., Kalhoro, D. H., Kalhoro, M. S., Metwally, E., Chughtai, M. I., Mazhar, M. U., & Khan, S. A. (2021) · Animal Nutrition · doi:10.1016/j.aninu.2020.11.005 · Cited by 110
Adipose tissue and reproduction in women
BOHLER, H. C. L., Mokshagundam, S. L., & Winters, S. J. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.03.079 · Cited by 110
The Glucocorticoid Receptor Gene and Its Association to Metabolic Syndrome
Rosmond, R. (2002) · Obesity Research · doi:10.1038/oby.2002.146 · Cited by 89
Michailidou, Z., Turban, S., Miller, E., Zou, X., Schrader, J., Ratcliffe, P. J., Hadoke, P. W. F., Walker, B. R., Iredale, J. P., Morton, N. M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.259325 · Cited by 93
Self-citationTomlinson, J. W., Sherlock, M., Hughes, B., Hughes, S. V., Kilvington, F., Bartlett, W., Courtney, R., Rejto, P., Carley, W., & Stewart, P. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2325 · Cited by 98
Modulation of glucocorticoid metabolism by the growth hormone – IGF‐1 axis
Agha, A., & Monson, J. P. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02763.x · Cited by 108
Ligand-Conjugated Quantum Dots Monitor Antigen Uptake and Processing by Dendritic Cells
Cambi, A., Lidke, D. S., Arndt-Jovin, D. J., Figdor, C. G., & Jovin, T. M. (2007) · Nano Letters · doi:10.1021/nl0700503 · Cited by 105
Down-Regulation of Honey Bee IRS Gene Biases Behavior toward Food Rich in Protein
Wang, Y., Mutti, N. S., Ihle, K. E., Siegel, A. J., Dolezal, A. G., Kaftanoğlu, O., & Amdam, G. V. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000896 · Cited by 107
“The association between metabolic biology and behavior is of much interest since human food-choice and eating behavior contribute to many public health-issues such as obesity and diabetes [4].”
BackgroundModulation of Early Human Preadipocyte Differentiation by Glucocorticoids
Tomlinson, J. J., Boudreau, A., Wu, D., Atlas, E., & Haché, R. J. G. (2006) · Endocrinology · doi:10.1210/en.2006-0267 · Cited by 96
“In animal models, overexpression of 11 -HSD1 in mature adipocytes has provided a transgenic model for visceral obesity (3).”
BackgroundDe Novo Synthesis of Steroids and Oxysterols in Adipocytes
Li, J., Daly, E., Campioli, E., Wabitsch, M., & Papadopoulos, V. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.534172 · Cited by 95
“It has been widely recognized that the increased local regeneration of cortisol from circulating inert cortisone, through the increased activity of 11 -HSD1 in adipose tissues of obese individuals, amplifies fat cell differentiation and accounts for the metabolic complications of obesity (35).”
BackgroundAsada, M., Rauch, A., Shimizu, H., Maruyama, H., Miyaki, S., Shibamori, M., Kawasome, H., Ishiyama, H., Tuckermann, J., & Asahara, H. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2010.170 · Cited by 105
Cushing's syndromes, insulin resistance and endocrinopathic laminitis
Johnson, P. J., Messer, N. T., & Ganjam, V. K. (2004) · Equine Veterinary Journal · doi:10.2746/0425164044877279 · Cited by 106
Li, T., Li, S., Lijuan, D., Wang, N., Guo, M., Zhang, J., Yan, F., & Zhang, H. (2010) · Food Chemistry · doi:10.1016/j.foodchem.2010.01.039 · Cited by 105
Peroxisome Proliferators‐Activated Receptor (PPAR) Modulators and Metabolic Disorders
Cho, M.-C., Lee, K., Paik, S.-G., & Yoon, D.-Y. (2008) · PPAR Research · doi:10.1155/2008/679137 · Cited by 89
“In addition, insulin-resistant diabetes, hyperlipidemia, and hyperphagia were observed in 11β-HSD1 transgenic mice [20].”
BackgroundWhat are subcutaneous adipocytes really good for…?
Paus, R., Klein, J., Permana, P. A., Owecki, M., Chaldakov, G. N., Böhm, M., Hausman, G., Lapière, C. M., Atanassova, P., Sowiński, J., et al. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2006.00519_1.x · Cited by 92
Glucocorticoid Receptor and Adipocyte Biology
Lee, R. A., Harris, C. A., & Wang, J.-C. (2018) · Nuclear Receptor Research · doi:10.32527/2018/101373 · Cited by 89
“Interestingly, transgenic expression of 11β-HSD1 limited to adipose tissue, results in mice with metabolic syndrome while fed a chow diet [9].”
BackgroundBudge, H., Gnanalingham, M. G., Gardner, D. S., Mostyn, A., Stephenson, T., & Symonds, M. E. (2005) · Birth Defects Research Part C: Embryo Today: Reviews · doi:10.1002/bdrc.20044 · Cited by 95
Cortisol and Its Relation to Insulin Resistance before and after Weight Loss in Obese Children
Reinehr, T., & Andler, W. (2004) · Hormone Research in Paediatrics · doi:10.1159/000079841 · Cited by 91
“This process may be relevant especially in central obesity by the action of the 11β-HSD1 in omental fat tissue [”
BackgroundMedical Implications of Obesity in Horses—Lessons for Human Obesity
Johnson, P. J., Wiedmeyer, C. E., Messer, N. T., & Ganjam, V. K. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300119 · Cited by 104
Molecular Basis of Health and Disease
Das, U. N. (2011) · Springer eBooks · doi:10.1007/978-94-007-0495-4 · Cited by 103
Blouin, K., Nadeau, M., Mailloux, J., Daris, M., Lebel, S., Luu-The, V., & Tchernof, A. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00039.2008 · Cited by 91
“(24) led to the demonstration that increased local cortisol production by 11 -HSD-1 may be one of the causal factors in the etiology of visceral obesity.”
Metabolic syndrome X: An inflammatory condition?
Das, U. N. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0014-8 · Cited by 103
Weight Loss Increases 11β-Hydroxysteroid Dehydrogenase Type 1 Expression in Human Adipose Tissue
Tomlinson, J. W., Moore, J. S., Clark, P. M. S., Holder, G., Shakespeare, L., & Stewart, P. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031376 · Cited by 90
“Further evidence for its differentiative role is derived from mice over-expressing 11β-HSD1 under the aP2 promoter that develop obesity as a result of increased adipocyte size due to a tissue specific increase in corticosterone concentrations (5).”
Omental 11β‐hydroxysteroid Dehydrogenase 1 Correlates with Fat Cell Size Independently of Obesity
Michailidou, Z., Jensen, M. D., Dumesic, D. A., Chapman, K. E., Seckl, J. R., Walker, B. R., & Morton, N. M. (2007) · Obesity · doi:10.1038/oby.2007.618 · Cited by 102
“This hypothesis has been supported by the observation that transgenic mice overexpressing 11 HSD1 in adipose tissue develop visceral obesity and the phenotype of the metabolic syndrome (12,15).”
BackgroundInfluentialSelf-citationRole of glucocorticoids in mediating effects of fasting and diabetes on hypothalamic gene expression
Makimura, H., Mizuno, T. M., Isoda, F., Beasley, J., Silverstein, J. H., & Mobbs, C. V. (2003) · BMC Physiology · doi:10.1186/1472-6793-3-5 · Cited by 102
“This hypothesis is particularly compelling since recent data suggest that aberrant glucocorticoid activity may play a key role in the development of the metabolic syndrome [10].”
BackgroundBlüher, M., Patti, M.-E., Gesta, S., Kahn, B. B., & Kahn, C. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404569200 · Cited by 86
Estrogens protect male mice from obesity complications and influence glucocorticoid metabolism
Dakin, R. S., Walker, B. R., Seckl, J. R., Hadoke, P. W. F., & Drake, A. J. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.102 · Cited by 92
“42 The DIO-induced reduction in 11 β -HSD1 mRNA and activity in subcutaneous adipose tissue which occurred in both sexes in our study has previously been reported in male rodents 34, 43 and has been proposed as a protective mechanism to reduce both circulating glucocorticoid concentrations and…”
Self-citationHossen, M. N., Kajimoto, K., Akita, H., Hyodo, M., Ishitsuka, T., & Harashima, H. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.07.100 · Cited by 100
“type 2 diabetes, hypertension, cardiovascular diseases, stroke and certain types of cancer such as colorectal, breast and prostate cancer [5-8]) which constitute the greatest threat to global human health [9].”
BackgroundExpanding the definition of hypothalamic obesity
Hochberg, I., & Hochberg, Z. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00727.x · Cited by 88
“Transgenic mice with overexpression of 11b-HSD1 selectively in adipose tissue gain and have a disproportionate accumulation of visceral fat depots (103).”
BackgroundLocal cortisol/corticosterone activation in skin physiology and pathology
Terao, M., & Katayama, I. (2016) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2016.06.014 · Cited by 100
Chennathukuzhi, V. M., Stein, J. M., Abel, T. G., Donlon, S., Yang, S., Miller, J. P., Allman, D. M., Simmons, R. A., & Hecht, N. B. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.18.6419-6434.2003 · Cited by 100
“However, it is possible that the absence of TB-RBP induces an adipose tissue-specific abnormality in glucocorticoid action or metabolism, resulting in elevated levels of corticosterone ( 37 ), which in turn would induce an accumulation of visceral fat.”
BackgroundMedicinal Chemistry of Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1)
Scott, J. S., Goldberg, F. W., & Turnbull, A. V. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4014746 · Cited by 99
Concerted Action of Aldehyde Dehydrogenases Influences Depot-Specific Fat Formation
Reichert, B., Yasmeen, R., Jeyakumar, S. M., Yang, F., Thomou, T., Alder, H., Duester, G., Maiseyeu, A., Mihai, G., Harrison, E. H., et al. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0465 · Cited by 99
Livingstone, D. E. W., & Walker, B. R. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044842 · Cited by 99
“A similar magnitude of increased adipose 11 -HSD1 activity in adipose, produced by transgenic overexpression of rat 11 -HSD1 in mouse adipose under the Ap2 promoter, resulted in dramatic central obesity, insulin resistance, diabetes mellitus, and dyslipidemia (Masuzaki et al., 2001).”
BackgroundEndocrine causes of nonalcoholic fatty liver disease
Marino, L., & Jornayvaz, F. R. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i39.11053 · Cited by 100
Lee, J. H., Bullen, J. W., Stoyneva, V. L., & Mantzoros, C. S. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00184.2004 · Cited by 81
“Initial studies in mice suggested that resistin induces insulin resistance, but subsequent animal studies revealed conflicting data regarding whether resistin expression is increased (38, 39) or decreased (16, 19, 25, 26, 43) in obesity, and decreased (12, 27, 36, 38, 39) or increased (8, 43) by thiazolidinediones (TZ…”
BackgroundZeng, X., Jedrychowski, M. P., Chen, Y., Serag, S., Lavery, G. G., Gygi, S. P., & Spiegelman, B. M. (2016) · Genes & Development · doi:10.1101/gad.285312.116 · Cited by 99
“This same phenomenon was also observed with the adipose-specific HSD11B1 transgenic mouse (Masuzaki et al. 2001).”
InfluentialEberle, C., Fasig, T., Brüseke, F., & Stichling, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245386 · Cited by 99
“Moreover, these mice exhibited insulin resistance and diabetes [17].”
BackgroundCaron‐Jobin, M., Morisset, A., Tremblay, A., Huot, C., Légaré, D., & Tchernof, A. (2011) · Obesity · doi:10.1038/oby.2011.90 · Cited by 98
“This enzyme has been shown to increase adipose tissue glucocorticoid content, and its overexpression in fat tissues of transgenic mice leads to abdominal obesity and the metabolic syndrome (37).”
BackgroundHirata, A., Maeda, N., Nakatsuji, H., Hiuge-Shimizu, A., Okada, T., Funahashi, T., & Shimomura, I. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.139 · Cited by 98
Boullu‐Ciocca, S., Achard, V., Tassistro, V., Dutour, A., & Grino, M. (2007) · Diabetes · doi:10.2337/db07-1316 · Cited by 98
“Transgenic mice with adipocyte-targeted 11 -HSD-1 overexpression developed a visceral obesity that was exaggerated by a high-fat diet (9).”
BackgroundAdipose tissue renin–angiotensin–aldosterone system (RAAS) and progression of insulin resistance
Marcus, Y., Shefer, G., & Stern, N. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.021 · Cited by 97
“The increase in adipose levels of cortisol did not correlate with its plasma levels which remained unchanged (Masuzaki et al., 2001).”
BackgroundHart, K. A., Wochele, D. M., Norton, N. A., McFarlane, D., Wooldridge, A. A., & Frank, N. (2016) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.13839 · Cited by 98
Impact of Glucocorticoid Excess on Glucose Tolerance: Clinical and Preclinical Evidence
Pasieka, A., & Rafacho, A. (2016) · Metabolites · doi:10.3390/metabo6030024 · Cited by 90
“Adipose-specific 11β-HSD1 over-expression in mice (in subcutaneous and epididymal depots) results in obesity and IR in mice [85], whereas inhibiting 11β-HSD1 enhanced adipose insulin sensitivity [86].”
BackgroundAldosterone: Its Receptor, Target Genes, and Actions
Pearce, D., Bhargava, A., & Cole, T. J. (2003) · Vitamins and hormones · doi:10.1016/s0083-6729(03)01002-1 · Cited by 98
1, 25‐Dihydroxyvitamin D3 Modulation of Adipocyte Glucocorticoid Function
Morris, K. L., & Zemel, M. B. (2005) · Obesity Research · doi:10.1038/oby.2005.75 · Cited by 81
Pietiläinen, K. H., Rissanen, A., Kaprio, J., Mäkimattila, S., Häkkinen, A.-M., Westerbacka, J., Sutinen, J., Vehkavaara, S., & Yki-Järvinen, H. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00381.2004 · Cited by 90
“Overexpression of 11 -hydroxysteroid dehydrogenase-1, the enzyme producing cortisol in adipose tissue, leads to insulin resistance in animals (19) and characterizes both obese (48, 49) and lipoatrophic (40) human adipose tissue.”
BackgroundAm J Physiol Regulatory Integrative Comp Physiol
Vranić, M., Riddell, M. C., Campbell, J. E., Kiràly, M. A., Atkinson, D. J., & D'souza, A. M. (2010) · Cited by 97
Courtney, R., Stewart, P. M., Toh, M., Ndongo, M.-N., Calle, R. A., & Hirshberg, B. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1912 · Cited by 90
“Compared with current antidiabetic agents on the market, an 11 HSD1 inhibitor may ameliorate a number of comorbidities that occur in diabetic patients including hypertension (13), dyslipidemia, and visceral adiposity and therefore could be used to treat aspects of the metabolic syndrome (8, 9).”
BackgroundMethodInfluentialDehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue
Apostolova, G., Schweizer, R. A. S., Balazs, Z., Kostadinova, R. M., & Odermatt, A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00442.2004 · Cited by 89
“The importance of the local activation of glucocorticoids in adipose tissue has been demonstrated recently in transgenic mice overexpressing 11 -HSD1 under the adipose-specific AP2 promoter/enhancer (30).”
BackgroundA novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis
Bujalska, I. J., Gathercole, L. L., Tomlinson, J. W., Darimont, C., Ermolieff, J., Fanjul, A. N., Rejto, P. A., & Stewart, P. M. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0050 · Cited by 84
“…tolerance through reduced gluconeogenesis and hepatic glucose output (Kotelevtsev et al. 1997, Morton et al. 2001), while targeted overexpression of 11b-HSD1 in adipose tissue recapitulates features of the MS including central adiposity (Masuzaki et al. 2001).”
BackgroundDieudonné, M., Sammari, A., Santos, E. D., Leneveu, M.-C., Giudicelli, Y., & Pecquery, R. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.01.007 · Cited by 94
Liu, Y., Nakagawa, Y., Wang, Y., Li, R., Li, X., Ohzeki, T., & Friedman, T. C. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1409 · Cited by 79
“Transgenic mice overexpressing 11 -HSD1 in adipose tissue develop visceral obesity when fed a high-fat diet (16).”
BackgroundBerthiaume, M., Laplante, M., Festuccia, W., Gélinas, Y., Poulin, S., Lalonde, J., Joanisse, D. R., Thieringer, R., & Deshaies, Y. (2007) · Endocrinology · doi:10.1210/en.2006-1199 · Cited by 82
Draper, N., Echwald, S. M., Lavery, G. G., Walker, E. A., Fraser, R., Davies, E., Sørensen, T. I. A., Astrup, A., Adamski, J., Hewison, M., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011375 · Cited by 81
Laminitis and the Equine Metabolic Syndrome
Johnson, P. J., Wiedmeyer, C. E., LaCarrubba, A. M., Ganjam, V. K., & Messer, N. T. (2010) · Veterinary Clinics of North America Equine Practice · doi:10.1016/j.cveq.2010.04.004 · Cited by 93
Ertel, K. A., Koenen, K. C., Rich-Edwards, J. W., & Gillman, M. W. (2010) · Paediatric and Perinatal Epidemiology · doi:10.1111/j.1365-3016.2010.01098.x · Cited by 92
Endocrinopathic laminitis in the horse
Johnson, P. J., Messer, N. T., Slight, S. H., Wiedmeyer, C. E., Buff, P. R., & Ganjam, V. K. (2004) · Clinical techniques in equine practice · doi:10.1053/j.ctep.2004.07.004 · Cited by 92
Corticotropin-Releasing Hormone System in Human Adipose Tissue
Seres, J., Bornstein, S. R., Seres, P., Willenberg, H. S., Schulte, K. M., Scherbaum, W. A., & Ehrhart-Bornstein, M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031299 · Cited by 86
Structure-based molecular modeling in SAR analysis and lead optimization
Temml, V., & Kutil, Z. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.02.018 · Cited by 92
Drake, A. J., Livingstone, D. E. W., Andrew, R., Seckl, J. R., Morton, N. M., & Walker, B. R. (2005) · Endocrinology · doi:10.1210/en.2004-1063 · Cited by 77
“Evidence from animal models of genetic obesity suggest that changes in peripheral glucocorticoid metabolism may be important in the pathogenesis of obesity and/or its metabolic sequelae (2, 7, 8, 26).”
BackgroundInfluentialSelf-citationChronic social stress, hedonism and vulnerability to obesity: Lessons from Rodents
Coccurello, R., D'Amato, F. R., & Moles, A. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.05.018 · Cited by 91
Liver X receptors in cardiovascular and metabolic disease
Geyeregger, R., Zeyda, M., & Stulnig, T. M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5398-3 · Cited by 91
Xiang, J. S., Ipek, M., Suri, V., Massefski, W. W., Pan, N., Ge, Y., Tam, M., Xing, Y., Tobin, J. F., Xu, X., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.03.093 · Cited by 91
Circadian Rhythm Gene Period 3 Is an Inhibitor of the Adipocyte Cell Fate
Costa, M. J., So, A. Y.-L., Kaasik, K., Krueger, K. C., Pillsbury, M. L., Fu, Y.-H., Ptacek, L. J., Yamamoto, K. R., & Feldman, B. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.164558 · Cited by 83
11β-HSD1 Inhibitors for the Treatment of Type 2 Diabetes and Cardiovascular Disease
Anderson, A., & Walker, B. R. (2013) · Drugs · doi:10.1007/s40265-013-0112-5 · Cited by 90
“Transgenic mice over-expressing 11bHSD1 selectively in adipose tissue display visceral obesity, insulin resistance, hyperlipidaemia [9] and hypertension [10].”
BackgroundZhao, H., Li, S., Zhang, J., Che, G., Zhou, M., Liu, M., Zhang, C., Xu, N., Lin, L., Liu, Y., et al. (2016) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.06.058 · Cited by 89
“It was well known that the hyperlipidemia could cause the inducement of many diseases, such as atherosclerosis and cardiovascular disease (Masuzaki, Paterson, Shinyama, Morton, Mullins, Seckl, & Filer, 2001).”
Background11β-hydroxysteroid dehydrogenases: A growing multi-tasking family
Gómez-Sánchez, E. P., & Gómez-Sánchez, C. E. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111210 · Cited by 89
“GR and its transcriptional targets required for lipid accumulation in adipocytes were increased in these mice, they developed hyperlipidemia, insulin resistance, hyperglycemia, and hypertension when fed standard chow, and had a greater response to an obesogenic diet than control mice (Masuzaki et al., 2001).”
BackgroundTarantino, G. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i40.6735 · Cited by 82
Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes
Gathercole, L., & Stewart, P. M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.03.060 · Cited by 89
Justesen, J., Mosekilde, L., Holmes, M., Stenderup, K., Gasser, J., Mullins, J. J., Seckl, J. R., & Kassem, M. (2004) · Endocrinology · doi:10.1210/en.2003-1427 · Cited by 79
Self-citationLee, C. Y. (2013) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2013.11 · Cited by 89
“In order to understand the mechanism of excessive glucocorticoids-induced growth of visceral fat, Matsuzaki et al.(84) conducted an experiment using mice, which overexpress 11b-HSD1 selectively in the adipose tissues.”
BackgroundDepot‐specific steroidogenic gene transcription in human adipose tissue
MacKenzie, S. M., Huda, S. S., Sattar, N., Fraser, R., Connell, J. M. C., & Davies, E. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03262.x · Cited by 83
IL-17 inhibits adipogenesis in part via C/EBPα, PPARγ and Krüppel-like factors
Ahmed, M., & Gaffen, S. L. (2013) · Cytokine · doi:10.1016/j.cyto.2012.12.007 · Cited by 86
“Glucocorticoids are potent regulators of adipose differentiation [39,40].”
Background
Metadata
- Authors
- Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- University of Edinburgh (GB)
- Corresponding author
- Flier, Jeffrey S.
- Venue
- Science
- Published
- 2001-12-07
- Volume
- 294
- Issue
- 5549
- Pages
- 2166-2170
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2117268230
- Cited by
- 1,766
- References
- 34
- Citations by year
- 2026: 9 · 2025: 21 · 2024: 30 · 2023: 19 · 2022: 23 · 2021: 44 · 2020: 34 · 2019: 39 · 2018: 54 · 2017: 52 · 2016: 63 · 2015: 74 · 2014: 72 · 2013: 106 · 2012: 98
- FWCI
- 71.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- visceral obesity, metabolic syndrome, 11β-hydroxysteroid dehydrogenase type 1, glucocorticoids, corticosterone, adipose tissue, transgenic mice, insulin resistance, diabetes mellitus, hyperlipidemia, hyperphagia, leptin, high-fat diet
- MeSH terms
- Abdomen, Adipose Tissue, Animals, Body Composition, Corticosterone, Dietary Fats, Disease Models, Animal, Eating, Humans, Hydroxysteroid Dehydrogenases, Hyperglycemia, Hyperinsulinism, Insulin Resistance, Lipids, Lipoprotein Lipase, Male, Mice, Transgenic, Obesity, Receptors, Glucocorticoid, Viscera, Weight Gain, Adipocytes, Gene Targeting, Leptin, Metabolic Syndrome, 11-beta-Hydroxysteroid Dehydrogenase Type 1, Cell Size, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.